Roche Ramps Up Cancer Portfolio With $1.7bn Ignyta Buy

 
• By Kevin Grogan
  
Santa cap
Nice present: Ignyta is being acquired by Roche for $1.7bn • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business